ReviewVision (Basel, Switzerland)2026

Beyond Glycemic Control: Ocular Effects of Glucagon-like Peptide-1 Receptor Agonists.

Filippo Lixi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.